troglitazone has been researched along with Complication, Postoperative in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakai, I | 1 |
| Uchiyama, K | 1 |
| Mitsuo, M | 1 |
| Mizuta, N | 1 |
| Okamoto, M | 1 |
| Nakajima, H | 1 |
| Yoshimura, N | 1 |
| Omori, Y | 1 |
| Oka, T | 1 |
1 other study available for troglitazone and Complication, Postoperative
| Article | Year |
|---|---|
Elimination of hyperinsulinemia after pancreas transplantation in rats.
Topics: Animals; Chromans; Hyperinsulinism; Hypoglycemic Agents; Male; Pancreas Transplantation; Portal Syst | 1999 |